Inaugural UC-Wide Drug Discovery Symposium

Inaugural UC-Wide Drug Discovery Symposium

By UC Braid - Drug, Device, Discovery and Development (D4) Group

Date and time

February 21, 2017 · 8am - February 22, 2017 · 12pm PST

Location

UCLA CNSI

570 Westwood Plaza Los Angeles, CA 90095

Description

Please join us for the upcoming UC Drug Discovery Symposium, hosted by UC Braid’s Drug, Device, Discovery and Development (D4) Group at UCLA’s California NanoSystems Institute.

Goals:

  • Highlight successful services and programs that support translational researchers across the UC campuses

  • Enable direct access to translational resources and infrastructure across all campuses for all investigators

  • Develop a comprehensive cross-campus drug discovery and development pipeline

  • Improve competitiveness of UC researchers for translational funding opportunities

**If you would like to present a poster, please submit your title and a brief abstract to cnsievents@cnsi.ucla.edu by February 15th.


Keynote Speakers:

  • Christine Gulbranson, Ph.D., M.B.A. - Senior Vice President, Research Innovation & Entrepreneurship, UCOP

  • Michael E. Jung, Ph.D. - Distinguished Professor, Chemistry and Biochemistry, Molecular and Medical Pharmacology; Director, David Geffen School of Medicine Bioscience Synthetic Chemistry Core, UCLA

  • James McKerrow, M.D., Ph.D. - Dean, Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD

  • Alan Verkman, M.D., Ph.D. - Professor, Medicine, UCSF School of Medicine

Invited Speakers:

  • Scott Baraban, Ph.D. - Professor, Neurological Surgery, UCSF School of Medicine

  • Seth Cohen, Ph.D. - Professor, Chemistry and Biochemistry, UCSD

  • Aimee Edinger, V.M.D., Ph.D. - Associate Professor, Developmental & Cell Biology; Equity Advisor, Ayala School of Biological Sciences, UC Irvine

  • Danica Fujimori, Ph.D. - Associate Professor, Cellular Molecular Pharmacology, UCSF School of Medicine

  • Bruce D. Hammock, Ph.D. - Distinguished Professor, Entomology & UCD Comprehensive Cancer Center Director, NIEHS-UCD Superfund Research Program PI, NIH Biotechnology Training Program, UC Davis

  • Hartmut Luecke, Ph.D. - Professor, Molecular Biology and Biochemistry; Physiology & Biophysics; Computer Science; Director, Center for Biomembrane Systems, UC Irvine

  • Mike Rogawski, M.D., Ph.D. - Professor, Neurology and Pharmacology, UC Davis

  • Jorge Torres, Ph.D. - Assistant Professor, Chemistry and Biochemistry, UCLA

  • Varghese John, Ph.D. - Visiting Assistant Professor, Neurology

  • Steven L. Wagner, Ph.D. - Associate Professor in Residence, Neurosciences, UCSD

  • Anna Wu, Ph.D. - Director, JCCC Cancer Molecular Imaging; Professor, Molecular & Medical Pharmacology; Cellular and Molecular Pathology PhD Program, Crump Institute for Molecular Imaging, UCLA

Industry Panelists:

  • Jarrod Borkat, M.B.A. - Senior Director/Head, Global External Partnerships & Collaborations, Medimmune

  • Kenneth Bradley, Ph.D. - Head, Antibiotics Discovery at Roche Pharmaceutical Research and Early Development (pRED), Roche

  • Mary Faris, Ph.D., M.B.A. - Director, Centers for Therapeutic Innovation, Pfizer

  • Joseph D. Panetta, M.P.H. - President & CEO, Biocom

  • Katherine Widdowson, Ph.D. - Entrepreneur in Residence Chem, DPAc DPU US, RD, Alternative Discovery & Development, GSK

Organizers:

  • Robert Damoiseaux, Ph.D. - Director, Molecular Screening Shared Resource (MSSR); Associate Professor, Molecular & Medical Pharmacology, UCLA

  • Michael K. Gilson, M.D., Ph.D. - Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences; Co-Director, Center for Drug Discovery Innovation, UCSD

  • Catherine Tralau-Stewart, Ph.D. - Associate Director, Catalyst; Director, CTSI T1 Translational Research, UCSF


Organized by

Sales Ended